Uesawa Y - Search Results

1

Disproportionality Analysis of Hepatotoxic and Gastrointestinal Adverse Events Associated With Nintedanib Using the Japanese Adverse Drug Event Report (JADER) Database.

Fujiwara M, Ikesue H, Yamaoka K, Uchida M, Uesawa Y, Muroi N, Shimizu T. Fujiwara M, et al. Among authors: uesawa y. In Vivo. 2025 Jan-Feb;39(1):396-403. doi: 10.21873/invivo.13841. In Vivo. 2025. PMID: 39740899 Free PMC article.

2

Evaluation of Cardiac Adverse Events Associated with Carfilzomib Using a Japanese Real-World Database.

Nakao S, Uchida M, Satoki A, Okamoto K, Uesawa Y, Shimizu T. Nakao S, et al. Among authors: uesawa y. Oncology. 2022;100(1):60-64. doi: 10.1159/000519687. Epub 2021 Oct 21. Oncology. 2022. PMID: 34673654

3

Comprehensive Analysis of Bortezomib-Induced Adverse Events Using the Japanese Real-World Database.

Satoki A, Uchida M, Fujiwara M, Uesawa Y, Shimizu T. Satoki A, et al. Among authors: uesawa y. Oncology. 2022;100(3):188-194. doi: 10.1159/000521448. Epub 2021 Dec 14. Oncology. 2022. PMID: 34915520

4

Comprehensive analysis of everolimus-induced adverse events using the Japanese real-world database.

Uchida M, Nakano K, Fujiwara M, Uesawa Y, Shimizu T. Uchida M, et al. Among authors: uesawa y. J Clin Pharm Ther. 2022 Aug;47(8):1173-1180. doi: 10.1111/jcpt.13648. Epub 2022 Mar 22. J Clin Pharm Ther. 2022. PMID: 35316861

5

Comprehensive Analysis of Ixazomib-Induced Adverse Events Using the Japanese Pharmacovigilance Database.

Yamaoka K, Fujiwara M, Uchida M, Uesawa Y, Muroi N, Shimizu T. Yamaoka K, et al. Among authors: uesawa y. Oncology. 2022;100(7):413-418. doi: 10.1159/000524806. Epub 2022 May 3. Oncology. 2022. PMID: 35504255

6

Comprehensive Analysis of Adverse Events Induced by PARP Inhibitors Using JADER and Time to Onset.

Yamaoka K, Fujiwara M, Uchida M, Uesawa Y, Muroi N, Shimizu T. Yamaoka K, et al. Among authors: uesawa y. Life (Basel). 2022 Aug 31;12(9):1355. doi: 10.3390/life12091355. Life (Basel). 2022. PMID: 36143391 Free PMC article.

7

The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER.

Yamaoka K, Fujiwara M, Uchida M, Uesawa Y, Shimizu T. Yamaoka K, et al. Among authors: uesawa y. In Vivo. 2023 Jan-Feb;37(1):345-356. doi: 10.21873/invivo.13085. In Vivo. 2023. PMID: 36593055 Free PMC article.

8

Assessment of Time-to-onset and Outcome of Lung Adverse Events With Pomalidomide from a Pharmacovigilance Study.

Kawahara Y, Murata S, Shimizu T, Uesawa Y, Uchida M. Kawahara Y, et al. Among authors: uesawa y. In Vivo. 2023 Mar-Apr;37(2):955-961. doi: 10.21873/invivo.13168. In Vivo. 2023. PMID: 36881059 Free PMC article.

9

Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database.

Suga Y, Uchida M, Suzuki S, Sugawara H, Torigoe K, Futamura A, Uesawa Y, Nakagawa T, Takase H. Suga Y, et al. Among authors: uesawa y. Biol Pharm Bull. 2019;42(5):801-806. doi: 10.1248/bpb.b18-00997. Biol Pharm Bull. 2019. PMID: 31061323 Free article.

10

Analyses of Respiratory Depression Associated with Opioids in Cancer Patients Based on the Japanese Adverse Drug Event Report Database.

Sugawara H, Uchida M, Suzuki S, Suga Y, Uesawa Y, Nakagawa T, Takase H. Sugawara H, et al. Among authors: uesawa y. Biol Pharm Bull. 2019;42(7):1185-1191. doi: 10.1248/bpb.b19-00105. Biol Pharm Bull. 2019. PMID: 31257293 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters